# Nociplastic pain

Nociplastic pain, formerly known as central sensitisation, is a term used to describe chronic pain that persists without evidence of tissue injury, resulting in and being sustained by aberrant or heightened pain signal processing of the central nervous system. It may occur in combination with the other types of pain or in isolation. Its location may be generalised or multifocal, and it can be more intense than would be expected from any associated physical cause.
The concept and term was formally added to the taxonomy of the International Association for the Study of Pain following the recommendation of a task force in 2017. The root terms are Latin nocēre, meaning to hurt, and Greek πλαστός, meaning development or formation in a medical context.
This type of pain typically arises in some chronic pain conditions, with the archetypal condition being fibromyalgia. Exercise, psychotherapy, and medical therapies are commonly prescribed for such conditions. Nociplastic pain has also been hypothesized to play a role in the persistence of medically unexplained symptoms.

## Definition

Nociplastic pain is a longterm complex pain defined by the International Association for the Study of Pain as "pain that arises from altered nociception despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors or evidence for disease or lesion of the somatosensory system causing the pain". It is the third proposed mechanism for pain. The other two mechanisms are nociceptive pain and neuropathic pain. Widespread pain and increased pain have been suggested as important clinical features.
The terms "nociplastic pain" and "central sensitization" are sometimes used interchangeably. However, more recent articles argue that central sensitization is one of the significant mechanisms that contributes to nociplastic pain. Central sensitization is a broader term referring to a hyperexcitability of the nervous system, usually including hyperalgesia (increased sensitivity to pain), and allodynia (painful perception of non-painful stimuli).
Syndromes that are characterized by central nervous system excitability are referred to as central sensitivity syndromes.These include fibromyalgia, irritable bowel syndrome, headaches, chronic fatigue syndrome, and temporomandibular disorder.

## Proposed mechanisms

The causes of nociplastic pain are not fully understood and still being investigated, but it is thought to be a dysfunction of the central nervous system whose processing of pain signals may have become distorted or sensitised. There are a variety of proposed mechanisms for nociplastic pain, such as increased integration between parts of the brain responsible for emotion, sensory processing, and attention, increased levels of pain-inciting neurotransmitters, increased immune activity in the central and peripheral nervous systems, and alteration in muscle structure such as the formation of trigger points. Specific central nervous system locations that have been suggested to be the location of the dysfunction are nociceptive neurons, spinal and supraspinal structures, the dorsal horn and others.
There is research suggesting that chronic pain syndromes, such as irritable bowel syndrome, can potentially be triggered by viral illnesses (i.e. COVID-19) or bacterial infections in certain patient populations. It is theorized that viral infections may increase levels of inflammatory mediators, leading to pain receptor hyper-sensitization. However, more research is needed to explore and confirm the link between infections and chronic pain development as much of the data is self-reported.

## Diagnosis

Nociplastic pain is diagnosed by its clinical features and lack of response to regular painkillers. Pain is experienced in several body parts, and is often widespread and intense. There may be associated tiredness, and difficulties with memory, mood and sleep. It can occur on its own in conditions such as tension headache or fibromyalgia, or combined with other pain categories such as in chronic back pain.
Tools to measure central sensitization include sensory tests to painful stimuli, magnetic resonance imaging and measures of cytokines and neurotrophines in the blood and urine. Self-report questionnaires such as the Central Sensitization Inventory and the Sensory Hypersensitivity Scale are also used.

## Related symptoms

A 2014 review said that symptoms such as fatigue, sleep, memory and mood problems, and sensitivity to non-painful sensory stimuli were also CNS-driven symptoms that were inherent to nociplastic pain.

## Treatment

The treatment of nociplastic pain is often multifaceted. Treatment generally requires both physical and psychological therapies, pain neuroscience education, and sometimes pharmacological therapy.
There are multiple modalities of non-pharmacological treatment available that can help manage nociplastic pain. Exercise is commonly recommended because regular exercise increases the release of mood-elevating neurotransmitters and decreases inflammatory cells in the central nervous system. Transcutaneous electrical nerve stimulation (TENS) also helps to reduce pain by acting on inhibitory spinal cord receptors and activating pain-reducing receptors in the brain. Psychotherapy can also help patients with nociplastic pain to retrain their interpretation of and reaction to pain, improving quality of life.
Pharmacological treatment of nociplastic pain remains complex. Conventional pain management medications such as NSAIDs and opioids have shown limited usefulness in managing nociplastic pain. Currently, SNRI and TCA antidepressants are recommended, but their utility in managing this condition remains unclear.